Published Studies Related to Cleocin Vaginal (Clindamycin Vaginal)
Well-designed clinical trials related to Cleocin Vaginal (Clindamycin Vaginal)
[Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis]. [2011.02]
Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. [2008.01.15]
The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis. [2008.01]
The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis. [2007.04]
Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. [2006.06]
Oral clindamycin and histologic chorioamnionitis in women with abnormal vaginal flora. [2006.04]
An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations. [2005.12]
The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis. [2005.09]
Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. [2005.09]
[Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis] [2005.06]
A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. [2005]
Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. [2004.07]
Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. [2003.07.01]
Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. [2003.03.22]
Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. [2003.03]
The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. [2003]
Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis. [2001.10]
Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth. [2001.07]
Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. [2001.05]
Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis. [2001]
A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. [2000.11]
Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. [2000.08]
Potential patient preference for 3-day treatment of bacterial vaginosis: responses to new suppository form of clindamycin. [2000.05]
Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: a prospective, double-blinded, placebo-controlled, multicenter study. [2000.05]
Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. [2000]
Systemic absorption of clindamycin after intravaginal administration of clindamycin phosphate ovule or cream. [1999.08]
Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial. [1999.07]
[Therapy of bacterial vaginosis. Prospective clinical study ot the efficacy and tolerability of quaternary ammonium salts vs. clindamycin] [1998.03]
[Streptococcus group B and pregnancy: the therapeutic role of topical intravaginal clindamycin] [1997.05]
Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. [1995.11]
Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. [1995.11]
Bacterial vaginosis-associated microflora and effects of topical intravaginal clindamycin. [1994.11]
Treatment of bacterial vaginosis with a three day course of 2% clindamycin vaginal cream: a pilot study. [1994.04]
Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. [1994.04]
Placebo-controlled trial of intravaginal clindamycin 2% cream for the treatment of bacterial vaginosis. [1993.11]
Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. [1993.09]
Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. [1992.11]
Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. [1992.06]
Multicenter trial of prophylaxis with clindamycin plus aztreonam or cefotaxime in gynecologic surgery. [1991.05]
Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. [1990.09]
Bacterial vaginosis: diagnostic and pathogenetic findings during topical clindamycin therapy. [1990.08]
Preoperative clindamycin treatment and vaginal drainage in hysterectomy. [1989]
Well-designed clinical trials possibly related to Cleocin Vaginal (Clindamycin Vaginal)
Are antibiotics necessary after 48 hours of improvement in infected/septic abortions? A randomized controlled trial followed by a cohort study. [2011.04]
Probiotics for the treatment of bacterial vaginosis. [2009.10.07]
Antimicrobial resistance associated with the treatment of bacterial vaginosis. [2004.10]
Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial. [2003.10.10]
A new approach for the treatment of bacterial vaginosis: use of polyhexamethylene biguanide. A prospective, randomized study. [2003.09]
Antibiotic administration in patients with preterm premature rupture of membranes reduces the rate of histological chorioamnionitis: a prospective, randomized, controlled study. [2002.07]
Chorioamnionitis: is continuation of antibiotic therapy necessary after cesarean section? [1998.11]
Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. [1997.08]
Comparative study on vaginal or oral treatment of bacterial vaginosis. [1997.01]
Early ultrasound-guided transvaginal drainage of tubo-ovarian abscesses: a randomized study. [1996.06]
[Treatment of episiotomy wound infections. Incision and drainage versus incision, curettage and sutures under antibiotic cover--a randomized trial] [1994.08.22]
[New alternatives in the treatment of bacterial vaginosis] [1994.08]
Anaerobic coverage for intra-amnionic infection: maternal and perinatal impact. [1991.09]
Other research related to Cleocin Vaginal (Clindamycin Vaginal)
Rescreening for abnormal vaginal flora in pregnancy and re-treating with
clindamycin vaginal cream significantly increases cure and improvement rates. [2012]
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. [2011.09]
Vaginal retention of locally administered clindamycin. [2011.06]
Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clindamycin phosphate. [2010.07]
Effect of clindamycin treatment on vaginal inflammatory markers in pregnant women with bacterial vaginosis and a positive fetal fibronectin test. [2009.11]
[Mixed vaginitis prevalence in Latin-American women, according to physician perception. Preference, effectiveness and security of clindamycin plus ketoconazole] [2008.11]
[Ketoconazole and clindamycin efficacy vs oral clindamycin in premature membranes rupture prevention] [2008.07]
The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis. [2006.05]
Other possibly related research studies
The effect of second-trimester antibiotic therapy on the rate of preterm birth. [2007.01]
Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation? [2006.08]
Antibiotics for treating bacterial vaginosis in pregnancy. [2007.01.24]
Group B streptococcus toxic shock-like syndrome in a healthy woman: a case report. [2007.04]
Use of pH/whiff test or QuickVue Advanced pH and Amines test for the diagnosis of bacterial vaginosis and prevention of postabortion pelvic inflammatory disease. [2006]
Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes. [2007.12]
Duration of antimicrobial prophylaxis for group B streptococcus in patients with preterm premature rupture of membranes who are not in labor. [2007.10]
The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. [2007.05]
Predisposing factors for bacterial vaginosis, treatment efficacy and pregnancy outcome among term deliveries; results from a preterm delivery study. [2007.10.22]
Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy. [2007.06]
Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation. [2008]
The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. [2009.07.08]
Antibiotic resistance and penicillin tolerance in ano-vaginal group B streptococci. [2009.02]
[Toxic shock syndrome consecutive to the presence of vaginal tampon for menstruation regressive after early haemodynamic optimization and activated protein C infusion] [2009.01]
Treatment considerations for bacterial vaginosis and the risk of recurrence. [2009.12]
Antibiotics for ureaplasma in the vagina in pregnancy. [2011.09.07]
Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. [2011.08.19]
Group A streptococcal vaginitis: an unrecognized cause of vaginal symptoms in adult women. [2011.07]
Antimicrobial topical agents used in the vagina. [2011]
In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis? [2011.05]
Vaginitis: diagnosis and management. [2010.11]
Desquamative inflammatory vaginitis: differential diagnosis and alternate diagnostic criteria. [2010.10]
Dermatologic causes of vaginitis: a clinical review. [2010.10]
Vaginal carriage and antibiotic susceptibility profile of group B Streptococcus during late pregnancy in Ismailia, Egypt. [2009]
Antibiotics for ureaplasma in the vagina in pregnancy. [2011]
|
